Hematology & Oncology Doctors in Paducah, KY Accepting Medicare

5 Hematology & Oncology doctors found. Showing 1 - 5

Winston Chua, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2603 Kentucky Ave, Suite 403, Paducah, KY 42003 Phone: 270-444-3930    Fax: 270-442-5284

Dr. Charles F Winkler, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 100 Kiana Ct, Paducah, KY 42001 Phone: 270-554-0011    Fax: 270-554-6540

Dr. Luis A Concepcion, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2603 Kentucky Ave, Suite 403, Paducah, KY 42003 Phone: 270-444-3930    Fax: 270-442-5284

Dr. David C Ginn, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 100 Kiana Ct, Paducah, KY 42001 Phone: 270-554-0011    Fax: 270-554-6540

Dr. James R Gould, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 2603 Kentucky Ave, Suite 403, Paducah, KY 42003 Phone: 270-444-3930    Fax: 270-442-5284

News Archive

Study: Minority groups remain conspicuously absent from pancreatic cancer clinical trials

According to a study published today in Gastroenterology by researchers at Virginia Commonwealth University Massey Cancer Center and University of Florida Health, Black, Hispanic, Indigenous and Asian Americans remain conspicuously absent from pancreatic cancer clinical trials aimed at testing the most recent treatment advances for this deadly disease.

Virginia G. Piper, TGen and Scottsdale Healthcare begin AP26113 Phase 1 study in NSCLC

Patients at Virginia G. Piper Cancer Center Clinical Trials are the first in the nation to participate in a clinical trial to determine the safety, tolerability and preliminary activity of an investigational drug that targets cell-signaling proteins associated with the most common form of lung cancer, as well as other forms of cancer such as lymphomas and neuroblastoma.

Hepatectomy effective for treatment of caudate lobe HCC

Caudate hepatocellular carcinoma (HCC) has a poorer prognosis than HCC originating from other lobes, due to its proximity to the portal trunk and inferior vena cava, which facilitate intrahepatic and systemic spread early in the disease. Hepatic resection is considered, in principle, to be the first choice treatment. In order to improve surgical outcome, it is necessary to evaluate the potential risk factors affecting long-term survival and to establish guidelines for the appropriate use of hepatectomy for caudate lobectomy.

Healthland's EMR solution product enhancements to be showcased at 2010 HIMSS Conference

Healthland, America's market leader of healthcare information solutions for small community and critical access hospitals, today announced it will exhibit at the 2010 Annual HIMSS Conference and Exhibit, March 1- 4, 2010, in Atlanta at the Georgia World Congress Center. At the event, Healthland will conduct product demonstrations including its new Emergency Department Information System and Healthland Analytics, report results from a recent customer survey about the American Recovery and Reinvestment Act (ARRA) and meaningful use, and announce recent client success stories.

Read more Medical News

› Verified 9 days ago